October 17, 2018 — Nanosonics announced the commercial availability of its Trophon2 high level disinfection (HLD) system for ultrasound probe decontamination in the United States and Canada. The new device, which prevents exposure to hazardous chemicals, offers medical professionals a smart solution that helps ensure compliance with the latest guidelines for reprocessing of surface and endocavity ultrasound probes.

IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the Dolphin transmission detector for online monitoring of patient treatment.

Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The biodegradable SpaceOAR hydrogel is injected between the rectum and prostate to decrease a patient's exposure to rectal radiation and thereby reduce rectal radiation injury – one of the most common complications of prostate radiotherapy.

Technology may be threatening the very practice of radiology. Those who have built a career in the space have a passion for what they do, but are concerned with how technology may impact their space.

Radiologists are not averse to change and innovation — in fact, they believe that innovation can serve them, and the patients they care for, very well. Any technology or innovation that enables better patient care should be seriously considered.

Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog cousin

Explaining the Mammography Quality Standards Act

The Mammography Quality Standards Act (MQSA) was enacted to improve the quality of mammography and ensure that all women across the country can count on receiving a mammogram that meets quality standards. The MQSA program has many components, and here the U.S. Food and Drug Administration (FDA) explains how they all fit together:

A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team decision-making for complex coronary disease. Results also suggest the state-of-the-art imaging technology may offer a non-invasive diagnostic alternative to conventional coronary angiography. Coronary artery disease (CAD) and its complications are a leading cause of death throughout the world. According to therapeutic guidelines, left main or three vessel diseases represent the most severe, high-risk CAD cases, often requiring coronary bypass graft surgery (CABG) or percutaneous coronary intervention (PCI) as treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now